Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.065 EUR
78.36 M EUR
135.93 M EUR
343.88 M
About KANGJI MEDICAL HLDGS LTD
Sector
Industry
CEO
Ming Zhong
Website
Headquarters
Hangzhou
Founded
2004
FIGI
BBG00WCN3VF7
Kangji Medical Holdings Ltd. is an investment holding company mainly engaged in the design, development, manufacture and sale of a comprehensive suite of minimally invasive surgical instruments and accessories. Its disposable products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other disposable products. Reusable products comprise 4K endoscopic camera systems and other reusable products. The Company also engages in the provision of investment consultation services. Kangji Medical Holdings was founded by Ming Zhong and Yin Guang Shen Tu in August 2004 and is headquartered in Hangzhou, China.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange KANGJI MED.HLDS DL-,00001 stocks are traded under the ticker 50J.
We've gathered analysts' opinions on KANGJI MED.HLDS DL-,00001 future price: according to them, 50J price has a max estimate of 1.34 EUR and a min estimate of 0.96 EUR. Watch 50J chart and read a more detailed KANGJI MED.HLDS DL-,00001 stock forecast: see what analysts think of KANGJI MED.HLDS DL-,00001 and suggest that you do with its stocks.
Yes, you can track KANGJI MED.HLDS DL-,00001 financials in yearly and quarterly reports right on TradingView.
KANGJI MED.HLDS DL-,00001 is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
50J earnings for the last half-year are 0.03 EUR per share, whereas the estimation was 0.03 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are 0.03 EUR per share. See more details about KANGJI MED.HLDS DL-,00001 earnings.
KANGJI MED.HLDS DL-,00001 revenue for the last half-year amounts to 72.79 M EUR, despite the estimated figure of 74.44 M EUR. In the next half-year revenue is expected to reach 58.15 M EUR.
50J net income for the last half-year is 39.86 M EUR, while the previous report showed 37.02 M EUR of net income which accounts for 7.66% change. Track more KANGJI MED.HLDS DL-,00001 financial stats to get the full picture.
Yes, 50J dividends are paid annually. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 13.60%. Tracking KANGJI MED.HLDS DL-,00001 dividends might help you take more informed decisions.
KANGJI MED.HLDS DL-,00001 dividend yield was 4.17% in 2024, and payout ratio reached 48.73%. The year before the numbers were 15.57% and 228.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 30, 2025, the company has 1.01 K employees. See our rating of the largest employees — is KANGJI MED.HLDS DL-,00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KANGJI MED.HLDS DL-,00001 EBITDA is 76.50 M EUR, and current EBITDA margin is 56.27%. See more stats in KANGJI MED.HLDS DL-,00001 financial statements.
Like other stocks, 50J shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANGJI MED.HLDS DL-,00001 stock right from TradingView charts — choose your broker and connect to your account.